Rama Kondru
Chief Executive Officer
Since our founding, Emmes has played a critical role in advancing public health through data-driven clinical research.

Who we are
Science Driven
We uphold the highest scientific and ethical standards in every study we run.
Patient Focused
Patients are at the center of our work — improving lives is the measure of our success.
Stronger Together
We partner closely with sponsors, sites, and communities to achieve more together.

Emmes was founded in 1977 with a focus on biostatistics and public sector research, establishing a strong foundation as a scientific partner to the U.S. government - including the National Institutes of Health (NIH). Over time, we built an unmatched level of engagement across NIH Institutes and Centers, leading critical research initiatives that shaped public health and clinical trial best practices.
From the beginning, our business was designed to serve mission-driven programs - where scientific precision, regulatory rigor, and data transparency are essential to uncovering meaningful evidence. That early work with government sponsors became the springboard for our later expansion into commercial biopharma and global clinical research.

Emmes has played a leading role in addressing some of the world’s most urgent health challenges. Our teams have supported research on infectious diseases, blood disorders, and the opioid epidemic to name just a few areas. We continue to advance global health through partnerships with organizations like the Gates Foundation, PATH, and IAVI.
We’re also proud of our long-standing role in hematopoietic stem cell transplantation (HSCT) and ophthalmology research. We’ve helped develop the foundation for HSCT research since 2001. And we’ve helped lead landmark studies - including the AREDS and AREDS2 trials - that have shaped treatment guidelines and improved outcomes for patients with age-related eye diseases.

From the beginning, our business was designed to serve mission-driven programs — where scientific precision, regulatory rigor, and data transparency are essential to uncovering meaningful evidence.
We support biopharma organizations across the spectrum, from emerging biotech to established global firms, helping bring new therapies and treatments to life.
With a long-standing history supporting US and international government agencies, Emmes Group has played a leading role in clinical trials, epidemiological studies, and public health.
We proudly partner with mission-driven organizations that fund and lead critical research efforts.
Our collaborations with academic medical centers and universities extend promising research through large-scale, multicenter studies.
Emmes Group actively participates in public-private partnerships that bring together government, industry, academia, and non-profit stakeholders.
Learn more about our cloud-based suite of applications for study design, data capture, randomization and reporting.
Request a Meeting
Leadership